Corrigendum: TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations.

Frille, Armin; Boeschen, Myriam; Wirtz, Hubert; Stiller, Mathias; Bläker, Hendrik; von Laffert, Maximilian

Corrigendum: TP53 co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations.

Frille, Armin; Boeschen, Myriam; Wirtz, Hubert; Stiller, Mathias; Bläker, Hendrik; von Laffert, Maximilian.

Afiliação

Frille A; Department of Respiratory Medicine, Leipzig University, Leipzig, Germany.
Boeschen M; Institute of Pathology, Leipzig University, Leipzig, Germany.
Wirtz H; Department of Respiratory Medicine, Leipzig University, Leipzig, Germany.
Stiller M; Institute of Pathology, Leipzig University, Leipzig, Germany.
Bläker H; Institute of Pathology, Leipzig University, Leipzig, Germany.
von Laffert M; Institute of Pathology, Leipzig University, Leipzig, Germany.

Front Oncol ; 14: 1473239, 2024.

Article em En | MEDLINE | ID: mdl-39323997